Physiological Study of the Human CYP3A Activity (PiSA)
Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
Investigator-initiated physiological study to characterize the function of a major drug
metabolizing enzyme using a microdosed phenotyping probe to avoid unwanted,
concentration-dependent effects.